About your Search

20121112
20121120
Search Results 0 to 4 of about 5
work eventually, eventually, the emphasis is on eventually in this ticktock environment. not tomorrow but eventually. maybe a little bit tomorrow. let me just say that we're now going through a process. it's a process that's not unlike what happened last year when we faced the debt ceiling fiasco. everything's based on washington, isn't it? we fell 19% peak to trough before avoiding that catastrophe in the nick of time. and during that decline it didn't matter what you bought. you initially lost money regardless. it turned out to be, though, and this is the operative term for me, not just fiscal cliff, no pain no gain. it was a no pain no gain scenario. i think it's going to be this way this time around too. no pain no gain. today we found ourselves in the thick of you're going to lose money even on the best of stocks moment. i'm not going to deny it. when you have cisco report a magnificent quarter of tremendous guidance and you hardly get a gain, when you see a stock like home depot headed below where it was when it reported stellar results yesterday you have to accept that earnings
be thriving in an environment where lots of people are worried about their taxes going up year end and the fiscal cliff is starting to get top of mind. you have a stock like walmart which has been a juggernaut, going up in a straight line since april until the recent pullback. then there is a company like -- sell, sell, sell. jcpenney. if you thought things couldn't get worse for jcpenney under the ceo, well, you were very wrong. as the company missed estimates once again on friday, reporting absolutely hideous numbers, they were blinding. sure enough, penney's continued the decline today, down another $2.67, 13%. like the wheel of fortune, where she stops, nobody knows. far more important, just so you know, there is a piece of preferred, there is another corporate piece of paper affiliated with jcpenney and that is sinking like a stone. that is more valuable to tell how bad things at jcpenney are. johnson tried to revolutionize by getting rid of coupons, cutting price as cross the board, they failed tragically and they started issuing coupons again. customers don't trust them. jc
. >> these guys are important. unlike human beings, as we change the environment is bad for the environment, beavers form wetlands other species could move into. he's important. >> what else does he eat besides bananas? >> in the wild he would be eating all sorts of vegetation and they like to eat tree bark. he has teeth on them that are so much enamel that are bright orange. these guys chop down trees and build dams with them. >> you don't want to get in front of an angry beaver. >> bring out the owl. >> let me put the baby alligator away. the last animal is another species that would have been -- >> what are they called? >> barn owl. these are a species native to europe. european colonists would have been used to seeing these guys. they're not particularly common. these animals can find prey in pitch darkness. >> you're kidding. >> tests have been done on these species, they've removed every iota of light. just by their hearing they can find rodents which is their main prey. they are called barn owls, because they are one of the few species that can live in human structures and benefit fr
it is not a major league stock. it is the wrong stock for this environment. >> susan. >> how do you feel about exel? >> i like exel. and by the way, another one of -- another one of our specs, dbax, nice move today. remember, i am in favor of speculation as long as it's only one small piece of your portfolio. and that is the conclusion of the lightning round. a febreze experiment. can a 30-day-old pluggable febreze make even this old container smell fresh? take a deep breath. describe the room that you're in. i think just like a big, open space. like i'm hanging the sheets on the line. and it smells really fresh, man. let's take your blindfold off. oh! [ both laugh ] super-weird! oh, is it febreze? yeah. ohh, how about that? febreze has anti-clogging technology that keeps it smelling fresh, even after 30 days. febreze. breathe happy. i have a cold, and i took nyquil, but i'm still "stubbed" up. [ male announcer ] truth is, nyquil doesn't unstuff your nose. what? [ male announcer ] it doesn't have a decongestant. no way. [ male announcer ] sorry. alka-seltzer plus fights your worst cold symptoms plu
ones. i am searching for the companies that i like that can thrive in this environment with the fiscal cliff and with a recession a possibility. look, it's a possibility if they don't solve this thing. today i was throwing a surprise party for amgen. you know what, fiscal cliff, no fiscal cliff, we're still having an amgen party here. inappropriate balloon moment there. they make all kinds of drugs for many serious illnesses. it has seven products in development that are starting phase three clinical trials in the early part of next year. phase three means it's getting near fruition. amgen could double earnings per share over the next eight years. that is much better than a sharp stick in the retina. amgen reported on october 23rd after the close and the company delivered spectacular results and was a true triple play. earnings came in $1.67, and revenues 5.9% year over year. when the street was looking for $4.25 billion. management's four-year guidance, substantially higher than the analysts expecting. those were fabulous numbers. no surprise that the stock shot up from $87.32, to nea
Search Results 0 to 4 of about 5